Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Association between tuberculosis, diabetes and 25 hydroxyvitamin D in Tanzania: a longitudinal case control study
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 3657234
Author(s) Boillat-Blanco, Noémie; Bovet, Pascal; Ramaiya, Kaushik L; Mganga, Maliwasa; Minja, Lilian T; Saleh, Lanja; Imboden, Medea; Schindler, Christian; Gagneux, Sebastien; Daubenberger, Claudia; Reither, Klaus; Probst-Hensch, Nicole
Author(s) at UniBasel Imboden, Medea
Schindler, Christian
Gagneux, Sebastien
Daubenberger, Claudia
Reither, Klaus
Probst Hensch, Nicole
Year 2016
Title Association between tuberculosis, diabetes and 25 hydroxyvitamin D in Tanzania: a longitudinal case control study
Journal BMC Infectious Diseases
Volume 16
Number 1
Pages / Article-Number 626
Abstract BACKGROUND: Vitamin D level is inversely associated with tuberculosis (TB) and diabetes (DM). Vitamin D could be a mediator in the association between TB and DM. We examined the associations between vitamin D, TB and DM. METHODS: Consecutive adults with TB and sex- and age-matched volunteers were included in a case-control study in Dar es Salaam, Tanzania. Glycemia and total vitamin D (25(OH)D) were measured at enrolment and after TB treatment in cases. The association between low 25(OH)D (<75 nmol/l) and TB was evaluated by logistic regression adjusted for age, sex, body mass index, socioeconomic status, sunshine hours, HIV and an interaction between low 25(OH)D and hyperglycemia. RESULTS: The prevalence of low 25(OH)D was similar in TB patients and controls (25.8 % versus 31.0 %; p = 0.22). In the subgroup of patients with persistent hyperglycemia (i.e. likely true diabetic patients), the proportion of patients with low 25(OH)D tended to be greater in TB patients (50 % versus 29.7 %; p = 0.20). The effect modification by persistent hyperglycemia persisted in the multivariate analysis (pinteraction = 0.01). CONCLUSIONS: Low 25(OH)D may increase TB risk in patients with underlying DM. Trials should examine if this association is causal and whether adjunct vitamin D therapy is beneficial in this population.
Publisher BioMed Central
ISSN/ISBN 1471-2334
edoc-URL http://edoc.unibas.ch/44893/
Full Text on edoc Available
Digital Object Identifier DOI 10.1186/s12879-016-1960-x
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/27809789
ISI-Number WOS:000386972300004
Document type (ISI) Article
 
   

MCSS v5.8 PRO. 0.332 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
19/04/2024